Omega Healthcare Investors Files 8-K
Ticker: OHI · Form: 8-K · Filed: 2025-09-15T00:00:00.000Z
Sentiment: neutral
Topics: corporate-filing, regulatory-update
Related Tickers: OHI
TL;DR
OHI filed an 8-K on 9/15/25. Basic corporate info update.
AI Summary
Omega Healthcare Investors, Inc. filed an 8-K on September 15, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 303 International Circle, Suite 200, Hunt Valley, Maryland, 21030, with a business phone number of (410) 427-1700. This report is filed under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing provides an update on Omega Healthcare Investors' corporate information and regulatory filings, which is important for investors tracking the company's compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Omega Healthcare Investors, Inc. (company) — Registrant
- 303 International Circle, Suite 200, Hunt Valley, Maryland, 21030 (location) — Principal executive offices
- September 15, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' for Omega Healthcare Investors, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 15, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Omega Healthcare Investors, Inc.
Where are Omega Healthcare Investors, Inc.'s principal executive offices located?
Omega Healthcare Investors, Inc.'s principal executive offices are located at 303 International Circle, Suite 200, Hunt Valley, Maryland, 21030.
What is the registrant's telephone number?
The registrant's telephone number is (410) 427-1700.
From the Filing
0000888491-25-000029.txt : 20250915 0000888491-25-000029.hdr.sgml : 20250915 20250915161845 ACCESSION NUMBER: 0000888491-25-000029 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250915 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250915 DATE AS OF CHANGE: 20250915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 251314555 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20250915x8k.htm 8-K OMEGA HEALTHCARE INVESTORS, INC._September 15, 2025 0000888491 false 0000888491 2025-09-15 2025-09-15 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): September 15, 2025 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 par value OHI New York Stock Exchange ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ Item 8.01 Other Events. ​ On September 15, 2025, Omega Healthcare Investors, Inc. issued a press release announcing that it will redeem all of its outstanding 5.250% Senior Notes due 2026 on October 15, 2025. Pursuant to the terms of the indenture governing the notes, Omega will redeem the outstanding notes at a redemption price of 100% of their principal amount, plus accrued and unpaid interest to, but not including, the redemption date. On September 15, 2025, a copy of the irrevocable notice of redemption for such notes was mailed to record holders of the notes by U.S. Bank Trust Company, National Association, the trustee under the indenture governing the notes. ​ A copy of t